SYNLOGIC, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
SYNLOGIC, INC. (SYBX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $3.09 million as of 2023-12-31, per its 10-K filed 2024-03-19.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2024-03-19
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.09M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.48M.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.77M.
- 2020-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7.46M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2023-12-31 | $3.09M 10-K · filed 2024-03-19 |
| 2022-12-31 | $4.48M 10-K · filed 2023-03-29 |
| 2021-12-31 | $5.77M 10-K · filed 2022-03-17 |
| 2020-12-31 | $7.46M 10-K · filed 2021-03-25 |
| 2019-12-31 | $9.35M 10-K · filed 2020-03-12 |
| 2019-09-30 | $9.85M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $10.10M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $10.45M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |